These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
206 related items for PubMed ID: 21324129
1. Soybean-derived Bowman-Birk inhibitor inhibits neurotoxicity of LPS-activated macrophages. Li J, Ye L, Cook DR, Wang X, Liu J, Kolson DL, Persidsky Y, Ho WZ. J Neuroinflammation; 2011 Feb 15; 8():15. PubMed ID: 21324129 [Abstract] [Full Text] [Related]
2. Soybean-derived Bowman-Birk Inhibitor (BBI) Inhibits HIV Replication in Macrophages. Ma TC, Zhou RH, Wang X, Li JL, Sang M, Zhou L, Zhuang K, Hou W, Guo DY, Ho WZ. Sci Rep; 2016 Oct 13; 6():34752. PubMed ID: 27734899 [Abstract] [Full Text] [Related]
3. Bowman-Birk inhibitor suppresses autoimmune inflammation and neuronal loss in a mouse model of multiple sclerosis. Touil T, Ciric B, Ventura E, Shindler KS, Gran B, Rostami A. J Neurol Sci; 2008 Aug 15; 271(1-2):191-202. PubMed ID: 18544456 [Abstract] [Full Text] [Related]
4. In vivo anti-inflammatory efficacy of the combined Bowman-Birk trypsin inhibitor and genistein isoflavone, two biological compounds from soybean. Sadeghalvad M, Mohammadi-Motlagh HR, Karaji AG, Mostafaie A. J Biochem Mol Toxicol; 2019 Dec 15; 33(12):e22406. PubMed ID: 31593353 [Abstract] [Full Text] [Related]
5. Neuroprotective Activity of (-)-Epigallocatechin Gallate against Lipopolysaccharide-Mediated Cytotoxicity. Liu JB, Zhou L, Wang YZ, Wang X, Zhou Y, Ho WZ, Li JL. J Immunol Res; 2016 Dec 15; 2016():4962351. PubMed ID: 27191001 [Abstract] [Full Text] [Related]
6. Dietary supplementation of soybean kunitz trypsin inhibitor reduces lipopolysaccharide-induced lethality in mouse model. Kobayashi H, Yoshida R, Kanada Y, Fukuda Y, Yagyu T, Inagaki K, Kondo T, Kurita N, Suzuki M, Kanayama N, Terao T. Shock; 2005 May 15; 23(5):441-7. PubMed ID: 15834310 [Abstract] [Full Text] [Related]
8. Interleukin-10 plays a crucial role in suppression of experimental autoimmune encephalomyelitis by Bowman-Birk inhibitor. Dai H, Ciric B, Zhang GX, Rostami A. J Neuroimmunol; 2012 Apr 15; 245(1-2):1-7. PubMed ID: 22365083 [Abstract] [Full Text] [Related]
9. Inhibitory effect of Bowman-Birk protease inhibitor on autophagy in MDAMB231 breast cancer cell line. Kyani S, Akrami H, Mostafaei A, Akbari S, Salehi Z. J Cancer Res Ther; 2021 Apr 15; 17(2):504-509. PubMed ID: 34121699 [Abstract] [Full Text] [Related]
10. Bowman-Birk Inhibitor attenuates experimental autoimmune encephalomyelitis by delaying infiltration of inflammatory cells into the CNS. Dai H, Ciric B, Zhang GX, Rostami A. Immunol Res; 2011 Dec 15; 51(2-3):145-52. PubMed ID: 22095543 [Abstract] [Full Text] [Related]
11. Bowman-Birk inhibitor and genistein among soy compounds that synergistically inhibit nitric oxide and prostaglandin E2 pathways in lipopolysaccharide-induced macrophages. Dia VP, Berhow MA, Gonzalez De Mejia E. J Agric Food Chem; 2008 Dec 24; 56(24):11707-17. PubMed ID: 19053380 [Abstract] [Full Text] [Related]
12. Bowman-Birk inhibitor suppresses production of superoxide anion radicals in differentiated HL-60 cells. Ware JH, Wan XS, Kennedy AR. Nutr Cancer; 1999 Dec 24; 33(2):174-7. PubMed ID: 10368813 [Abstract] [Full Text] [Related]
13. Bowman-Birk inhibitor abates proteasome function and suppresses the proliferation of MCF7 breast cancer cells through accumulation of MAP kinase phosphatase-1. Chen YW, Huang SC, Lin-Shiau SY, Lin JK. Carcinogenesis; 2005 Jul 24; 26(7):1296-306. PubMed ID: 15746161 [Abstract] [Full Text] [Related]
14. Effect of the Bowman-Birk inhibitor (a soy protein) on in vitro bladder neck/urethral and penile corporal smooth muscle activity. Malkowicz SB, Liu SP, Broderick GA, Wein AJ, Kennedy AR, Levin RM. Neurourol Urodyn; 2003 Jul 24; 22(1):54-7. PubMed ID: 12478602 [Abstract] [Full Text] [Related]
15. Bowman-Birk protease inhibitor activates DNA-dependent protein kinase and reduces formation of radiation-induced dicentric chromosomes. Dittmann K, Virsik-Köpp P, Mayer C, Rave-Fränk M, Rodemann HP. Int J Radiat Biol; 2003 Oct 24; 79(10):801-8. PubMed ID: 14630539 [Abstract] [Full Text] [Related]
16. Detection of Bowman-Birk inhibitor and anti-Bowman-Birk inhibitor antibodies in sera of humans and animals treated with Bowman-Birk inhibitor concentrate. Wan XS, Serota DG, Ware JH, Crowell JA, Kennedy AR. Nutr Cancer; 2002 Oct 24; 43(2):167-73. PubMed ID: 12588697 [Abstract] [Full Text] [Related]
17. Soybean Bowman-Birk protease inhibitor (BBI): identification of the mechanisms of BBI suppressive effect on growth of two adenocarcinoma cell lines: AGS and HT29. Fereidunian A, Sadeghalvad M, Oscoie MO, Mostafaie A. Arch Med Res; 2014 Aug 24; 45(6):455-61. PubMed ID: 25014623 [Abstract] [Full Text] [Related]
18. The effect of docosahexaenoic acid (DHA) on expression of IL-1ß, IL-6, IL-8, and TNF-α in normal and lipopolysaccharide (LPS)-stimulated macrophages. Solanki P, Aminoshariae A, Jin G, Montagnese TA, Mickel A. Quintessence Int; 2013 Apr 24; 44(6):393. PubMed ID: 23534044 [Abstract] [Full Text] [Related]
19. Suppression of 3-methylcholanthrene-induced cellular transformation by timed administration of the Bowman-Birk protease inhibitor. St Clair WH. Carcinogenesis; 1991 May 24; 12(5):935-7. PubMed ID: 2029760 [Abstract] [Full Text] [Related]
20. The biochemical and functional food properties of the bowman-birk inhibitor. Losso JN. Crit Rev Food Sci Nutr; 2008 Jan 24; 48(1):94-118. PubMed ID: 18274967 [Abstract] [Full Text] [Related] Page: [Next] [New Search]